US 12263202
Method of treating melanocortin-4 receptor pathway-associated disorders
granted A61KA61K38/00A61K38/12
Quick answer
US patent 12263202 (Method of treating melanocortin-4 receptor pathway-associated disorders) held by RHYTHM PHARMACEUTICALS, INC. expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RHYTHM PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61K38/12, A61K9/0019, A61P